`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`EDWARDS LIFESCIENCES CORPORATION, EDWARDS LIFESCIENCES
`LLC, AND EDWARDS LIFESCIENCES AG
`Petitioners
`
`v .
`
`BOSTON SCIENTIFIC SCIMED, INC.
`Patent Owner
`
`____________
`
`Case IPR2017-00060
`Patent 8,992,608
`____________
`
`Before the Honorable NEIL T. POWELL, JAMES A. TARTAL, and ROBERT L.
`KINDER, Administrative Patent Judges.
`
`
`PETITIONERS’ AMENDED OBJECTIONS TO AMENDED
`DEMONSTRATIVES
`
`
`
`
`
`
`
`
`
`
`
`After serving demonstratives on Petitioners on December 8, 2017, and on
`
`the Board on December 12, Patent Owner amended its demonstratives in the
`
`version filed as Exhibit 2100 on December 19, reordering its slides and removing
`
`titles. Petitioners had timely filed their objections to Patent Owner’s slides (Paper
`
`No. 52) on December 15, based on the version served on December 8. Pursuant to
`
`the Board’s February 9, 2018 Decision (Paper No. 56 at 14) that “Petitioner is
`
`authorized to file, no later than February 16, 2018, an amended set of objections to
`
`Patent Owner’s demonstratives that contain no substantive changes from the
`
`originally filed objections other than to amend the identification of the slide that is
`
`the subject of the objection,” Petitioners herein provide an amended set of
`
`objections that identify the changes made to the slide numbers in the December 19
`
`submission (Exhibit 2100) from the original slides.1
`
`Objections to Exhibit 2100
`
`Petitioners maintain their scope objections (Papers 45, 51) to the new
`
`arguments and evidence Patent Owner improperly raises in its motion to exclude
`
`papers.
`
`
`1
`Per the Board’s order, the only substantive changes Petitioners have made to
`
`their objections are to update the slide numbers. Due to Patent Owner’s removal of
`
`the objected-to titles from Slide 3 (original slide 15) and Slide 4 (original slide 16),
`
`however, if acceptable to the Board, Petitioners would withdraw these objections.
`
`
`
`1
`
`
`
`
`
`Petitioners object to all of Patent Owner’s slides for failing to identify
`
`where in the papers any of these arguments were made or exhibits were cited.
`
`Petitioners object to Patent Owner’s Slide 59 (original slide 8) as improper
`
`new evidence and argument that does not appear in Patent Owner’s Response.
`
`Petitioners object to Patent Owner’s Slide 3 (original slide 15) for
`
`misstating the record because Dr. Buller testified that he has experience in surgical
`
`valve operations.
`
`Petitioners object to Patent Owner’s Slide 4 (original slide 16) to the extent
`
`that it states Dr. Buller has no experience with abdominal aortic aneurysms (AAA),
`
`which is contrary to Dr. Buller’s testimony.
`
`Petitioners object to Patent Owner’s Slide 13 (original slide 20) for
`
`misstating the record to the extent it suggests Elliot, Thornton, and Cook are
`
`limited to AAA stent grafts by omitting key portions of the quoted disclosures.
`
`Petitioners object to Patent Owner’s Slide 116 (original slide 108) as
`
`improper new evidence and argument in the form of dictionary definitions never
`
`before cited in Patent Owner’s Response and never entered into evidence.
`
`Petitioners object to Patent Owner’s Slide 52 (original slide 109) as
`
`improper new evidence and argument that does not appear in Patent Owner’s
`
`Response.
`
`
`
`2
`
`
`
`
`
`Petitioners object to Patent Owner’s Slide 53 (original slide 110) as
`
`improper new evidence and argument that does not appear in Patent Owner’s
`
`Response.
`
`Petitioners object to Patent Owner’s Slide 54 (original slide 111) as
`
`improper new evidence and argument that does not appear in Patent Owner’s
`
`Response.
`
`Petitioners object to Patent Owner’s Slide 55 (original slide 112) as
`
`improper new evidence and argument in the form of dictionary definitions never
`
`before cited in Patent Owner’s Response and never entered into evidence.
`
`
`
`Dated: February 12, 2018
`
`
`Respectfully submitted,
`
`
`
`/s/ Gregory S. Cordrey
`Gregory S. Cordrey, Esq. (Reg. No. 44,089)
`Brian P. Egan, Esq. (Reg. No. 54,866)
`Catherine Nyarady, Esq. (Reg. No. 42,042)
`Attorneys for Petitioners
`Edwards Lifesciences Corporation,
`Edwards Lifesciences LLC, and
`Edwards Lifesciences AG
`
`11532187
`
`
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that on February
`
`12, 2018, a complete and entire copy of PETITIONERS’ AMENDED
`
`OBJECTIONS TO AMENDED DEMONSTRATIVES has been served in its
`
`entirety by e-mail on the following addresses of record for Patent Owner:
`
`jennifer.sklenar@apks.com
`
`wallace.wu@apks.com
`
`marc.cohn@apks.com
`
`matthew.wolf@apks.com
`
`edward.han@apks.com
`
`Dated: February 12, 2018
`
`
`Respectfully submitted,
`
`
`
`/s/ Greogry S. Cordrey
`Gregory S. Cordrey, Esq. (Reg. No. 44,089)
`Brian P. Egan, Esq. (Reg. No. 54,866)
`Catherine Nyarady, Esq. (Reg. No. 42,042)
`Attorneys for Petitioners
`Edwards Lifesciences Corporation,
`Edwards Lifesciences LLC, and
`Edwards Lifesciences AG
`
`
`
`
`
`1
`
`